Ingrezza 60 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FCV5W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,268
Award facts
- Contract value 100% obligated
- $4,267.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Ingrezza 60 mg capsules (30-count units) valued at $4,267.66. This non-competitive delivery order represents a firm fixed price transaction with an ultimate completion date of January 12, 2026. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026, positioning the company as a critical pharmaceutical supplier to the Department of Defense.
Ingrezza (valbenazine) is a selective vesicular monoamine transporter 2 (VMAT2) inhibitor prescribed primarily for the treatment of tardive dyskinesia, a movement disorder that may develop as a side effect of antipsychotic medications used in military and veteran healthcare settings. As a child contract under the broader DLA pharmaceutical prime vendor vehicle, this order reflects AmerisourceBergen's established role as a major distributor of specialty pharmaceuticals and medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's competitive positioning within the federal procurement landscape is evidenced by its comprehensive product portfolio spanning multiple therapeutic domains and its proven capacity to meet stringent federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FCV5W?
SPE2DR26FCV5W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FCV5W worth?
The government has obligated $4,268 on SPE2DR26FCV5W.
Is contract SPE2DR26FCV5W an order under another contract?
Yes. SPE2DR26FCV5W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCV5W competed?
The extent of competition for SPE2DR26FCV5W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award